Keebeck Wealth Management, LLC Seagen Inc. Transaction History

Keebeck Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $1.64 Million - $1.85 Million	8,550 New	8,550 $1.81 Million
Q3 2021 Nov 16, 2021	SELL	$142.45 - $169.82 $213,674 - $254,730	-1,500 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $51,566 - $71,550	-375 Reduced 20.0%	1,500 $208,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $308,681 - $397,368	1,875 New	1,875 $328,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Keebeck Wealth Management, LLC with notifications on news.